BioMarin Pharmaceutical Inc at TD Cowen Healthcare Conference Transcript
Good morning, and welcome once again to TD Cowen's 46th Annual Healthcare Conference. I'm Phil Nadeau, one of the biotech analysts here at Cowen, and it's my pleasure to do a fireside chat with BioMarin Pharmaceutical. We have with us today, Alexander Hardy, the President and CEO; and Brian Mueller, the Executive Vice President and CFO and guys, maybe I'll kick it to you to begin.
Questions & Answers
Could you give a brief state of the company overview, biggest strengths, biggest challenges? And what is BioMarin need to achieve to outperform over the next year or two?
Well, thanks very much. Thanks, everybody, for joining us. So I've been CEO of BioMarin for the last two years and started off with a kind of a strategic refresh, what's the strategy of the company. It was very clear to me that BD should play a significant
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
